Volume 13, Issue 1 (Winter 2022)                   Caspian J Intern Med 2022, 13(1): 127-131 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azizianesh S, Rizvi F, Zainaldain H, Alesaeidi S. Ocular Manifestation in a patient with IgG4 Related Disease. Caspian J Intern Med 2022; 13 (1) :127-131
URL: http://caspjim.com/article-1-1896-en.html
Department of Rheumatology, Amir-Alam Hospital, Tehran, Iran , ahmad.23088@gmail.com
Abstract:   (2857 Views)
Background: IgG4-related disease is a newly recognized fibroinflammatory disease presenting with multiple features including mass forming lesion; a dense lymphoplasmacytic infiltrate; a characteristic histopathological appearance and often elevated serum of IgG4. This disease can potentially affect any organ and interestingly, the affected organs share common histopathological features including a dense lymphoplasmacytic infiltrate rich in IgG4-positive plasma cells, storiform fibrosis, and mild to moderate eosinophilia
Case Presentation: A 45-year-old man presented complaining of proptosis and gradual decrease in visual acuity of right eye. He had undergone many work-ups but without any definitive diagnosis. Through a combination of clinical and para-clinical investigations, the diagnosis of IgG4-RD was established. 693 mg/dL). Aggressive treatment (pulse of cyclophosphamide and pulse of corticosteroid) was started hoping to save the patient’s vision. Two weeks following the treatment, there was improvement with his visual acuity and proptosis.
Conclusion: In any patient with chronic tumor like lesions and pseudotumors without the evidence of malignancy, we should think of IgG4-related disease. In this circumstance, biopsy may lead us to the definitive diagnosis. Early diagnosis and treatment of IgG4-RD may inhibit further irreversible organ damages.
Full-Text [PDF 147 kb]   (1015 Downloads)    
Type of Study: case report | Subject: Reumatology
Received: 2019/05/12 | Accepted: 2021/08/2 | Published: 2022/01/20

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Caspian Journal of Internal Medicine

Designed & Developed by: Yektaweb